Compare PAHC & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PAHC | IART |
|---|---|---|
| Founded | 1946 | 1989 |
| Country | United States | United States |
| Employees | 2475 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2014 | 1996 |
| Metric | PAHC | IART |
|---|---|---|
| Price | $33.72 | $19.28 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 7 |
| Target Price | ★ $41.25 | $14.33 |
| AVG Volume (30 Days) | 277.6K | ★ 955.3K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.91% | N/A |
| EPS Growth | ★ 1883.33 | N/A |
| EPS | ★ 1.90 | N/A |
| Revenue | ★ $833,350,000.00 | N/A |
| Revenue This Year | $17.03 | $4.39 |
| Revenue Next Year | $3.82 | $3.40 |
| P/E Ratio | $18.18 | ★ N/A |
| Revenue Growth | ★ 4.12 | N/A |
| 52 Week Low | $25.58 | $8.70 |
| 52 Week High | $60.08 | $20.26 |
| Indicator | PAHC | IART |
|---|---|---|
| Relative Strength Index (RSI) | 51.33 | 61.98 |
| Support Level | $30.46 | $10.61 |
| Resistance Level | $34.57 | N/A |
| Average True Range (ATR) | 1.30 | 0.82 |
| MACD | 0.44 | 0.02 |
| Stochastic Oscillator | 67.13 | 68.00 |
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.